ICER and the West Health Policy Center announced a new collaboration to develop the 2026 “Launch Price and Access Report”, an independent analysis of drug prices and patient access for newly launched FDA-approved treatments. ICER published its first report in 2025.

The new Launch Price and Access Report, to be released in October 2026, will analyze launch price trends over four years (2022-2025). It will also include an in-depth review of patient access to newly launched drugs using real-world pharmacy and medical claims data, payer coverage policies, and direct patient surveys.

For questions please contact [email protected].